Central line: femoral - Revision history

Rossdonaldson1 at 20:43, 26 February 2025

2025-02-26T20:43:23Z

← Older revision		Revision as of 20:43, 26 February 2025
Line 2:		Line 2:
	[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]		[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]
	[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral vein visible in blue.)]]		[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral vein visible in blue.)]]
			[[File:Gray344.png\|thumb\|Cross section of the right hip at the level of the acetabulum.]]
	*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

Blsimpso: /* External Links */

2021-07-16T13:13:25Z

External Links

← Older revision		Revision as of 13:13, 16 July 2021
Line 67:		Line 67:

	==External Links==		==External Links==
	*[https://~~emedicine~~.~~medscape~~.com/~~article~~/~~80279~~-~~overview#showall Medscape~~ - Femoral ~~Central Venous Access~~]		*[https://www.merckmanuals.com/professional/critical-care-medicine/how-to-do-central-vascular-procedures/how-to-do-femoral-vein-cannulation?query=central%20line Merk Manual - How To Do Femoral Vein Cannulation]
			*[https://www.merckmanuals.com/professional/critical-care-medicine/how-to-do-central-vascular-procedures/how-to-do-femoral-vein-cannulation,-ultrasound-guided?query=central%20line Merk Manual - How To Do Femoral Vein Cannulation (Ultrasound-Guided)]

	===Videos===		===Videos===

Blsimpso: /* External Links */

2021-07-02T15:46:56Z

External Links

← Older revision		Revision as of 15:46, 2 July 2021
Line 67:		Line 67:

	==External Links==		==External Links==
			*[https://emedicine.medscape.com/article/80279-overview#showall Medscape - Femoral Central Venous Access]

	===Videos===		===Videos===

Blsimpso at 01:26, 29 June 2021

2021-06-29T01:26:00Z

← Older revision		Revision as of 01:26, 29 June 2021
Line 65:		Line 65:
	==See Also==		==See Also==
	{{Vascular access types}}		{{Vascular access types}}

			==External Links==

			===Videos===
			{{#widget:YouTube\|id=XUjncj6ybak}}

	==References==		==References==

Rossdonaldson1: /* Background */

2021-06-17T21:12:40Z

Background

← Older revision		Revision as of 21:12, 17 June 2021
Line 1:		Line 1:
	==Background==		==Background==
	[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]		[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]
	[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral ~~artery~~ visible in ~~red~~.)]]		[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral vein visible in blue.)]]
	*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

Rossdonaldson1: /* Background */

2021-06-17T21:12:17Z

Background

← Older revision		Revision as of 21:12, 17 June 2021
Line 1:		Line 1:
	==Background==		==Background==
	[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]		[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]
			[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral artery visible in red.)]]
	*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

Rossdonaldson1: /* Background */

2021-05-08T03:45:47Z

Background

← Older revision		Revision as of 03:45, 8 May 2021
Line 1:		Line 1:
	==Background==		==Background==
			[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]
	*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

Elcatracho: /* Complications */

2021-04-24T15:02:18Z

Complications

← Older revision		Revision as of 15:02, 24 April 2021
Line 54:		Line 54:
	*Vessel injury		*Vessel injury
	*Air embolism		*Air embolism
	*Cardiac dysrhythmia		*[[Arrhythmia\|Cardiac dysrhythmia]]
	*Nerve injury		*Nerve injury
	*Infection		*Infection
	*Thrombosis		*Thrombosis
	*Catheter misplacement		*Catheter misplacement
			*Bleeding

	==See Also==		==See Also==

Elcatracho: /* Background */

2021-04-24T15:01:17Z

Background

← Older revision		Revision as of 15:01, 24 April 2021
Line 1:		Line 1:
	==Background==		==Background==
	*Incidence of septicemia from femoral vein catheters is no different than the incidence for subclavian and internal jugular veins.<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

Rossdonaldson1: /* See Also */

2020-11-26T22:34:32Z

← Older revision		Revision as of 20:43, 26 February 2025
Line 2:		Line 2:
	[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]		[[File:Sobo 1909 573-574.png\|thumb\|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]]
	[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral vein visible in blue.)]]		[[File:Gray545.png\|thumb\|Right anterior femoral sheath laid open to show its three structures. (Femoral vein visible in blue.)]]
			[[File:Gray344.png\|thumb\|Cross section of the right hip at the level of the acetabulum.]]
	*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>		*Incidence of septicemia from femoral vein catheters may be no different than the incidence for [[Central line: subclavian\|subclavian]] and [[Central line: internal jugular\|internal jugular veins]].<ref>Parienti J-J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299:2413–2422.</ref><ref>Deshpande K, Hatem C, Ulrich H, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13–20.</ref>
	*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.		*Good site for access during resuscitation as does not interfere with compressions. It is not an ideal line for ACLS drugs due to length from heart, but good for post-resuscitation pressors and blood products.

← Older revision		Revision as of 22:34, 26 November 2020
Line 61:		Line 61:

	==See Also==		==See Also==
	*[[Central lines]]		{{Vascular access types}}

	==References==		==References==